The startup manufactures raw materials for biopharmaceuticals, providing essential nutrients for the growth of microorganisms and animal cells, along with a transient transfection platform for cell line development. This centralized access to critical components streamlines the cell culture process, enhancing efficiency for researchers and manufacturers in the biopharmaceutical industry.
Funding
$8.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Biopharmaceutical companies face challenges in sourcing consistent, high-quality raw materials for cell culture, which can impact cell growth, transfection efficiency, and ultimately, the yield and quality of biopharmaceuticals. Developing custom cell lines and optimizing media formulations in-house requires specialized expertise and resources, adding complexity and cost to the manufacturing process.
Solution
KCell Biosciences manufactures and supplies a comprehensive range of cell culture media, supplements, and services to streamline biopharmaceutical production. They offer both off-the-shelf basal media and customized media formulations tailored to specific cell types, including CHO, stem cells, and immune cells. In addition to media products, KCell provides cell line development services using a transient transfection platform, as well as contract manufacturing for custom media formulations in both powder and liquid forms. This allows biopharmaceutical companies to outsource media development and production, ensuring consistent quality and reducing internal resource requirements.
Target Audience
KCell Biosciences serves biopharmaceutical companies, cell-cultured meat industries, and research institutions requiring cell culture media, supplements, and cell line development services.
Features
- Serum-free and chemically defined cell culture media approved by global biopharmaceutical companies
- Customized cell culture media development services for recombinant proteins, stem cells, immune cells, and vaccines
- Basal media including DMEM, DMEM/F12, MEM, RPMI 1640, Ham’s F-12, M199, IMDM, and Leibovitz’s L-15 Medium
- Media supplements including Fetal Bovine Serum (FBS), cell freezing media, and growth factors
- Custom media manufacturing in powder and liquid forms with flexible capacity
- Cell line development services utilizing transient transfection technology
- Option to customize media formulation components such as glutamine, sodium pyruvate, and phenol red
- Capability to customize packaging specifications and inspection items